Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Somatostatinoma × vatalanib × Clear all

Phase

Status

Sponsor Class

OTHER 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Vipoma 1 Somatostatinoma 1 Insulinoma 1 Glucagonoma 1 Gliosarcoma 1 Glioblastoma 1 Gastrinoma 1 Central Nervous System Neoplasms 1 Carcinoma, Islet Cell 1

Interventions

Temozolomide 2 Octreotide 2 Capecitabine 2 vatalanib 1 motesanib diphosphate 1 batifiban 1 Everolimus 1 Etoposide 1 Cisplatin 1 Carboplatin 1 Biological Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00227773 2015-10-08

Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors

Eastern Cooperative Oncology Group

Phase 2 Withdrawn

Vipoma, Glucagonoma, Insulinoma, Somatostatinoma, Gastrinoma, Carcinoma, Islet Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡